Author Topic: Disease-modifying MS drugs may increase infection risk  (Read 83 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Disease-modifying MS drugs may increase infection risk
« on: December 13, 2017, 02:44:44 pm »
An article originally in MD Magazine and reprinted in Specialty Pharmacy Times (December 13) summarizes some of the infection risks associated with the various MS disease-modifying drugs:

https://www.specialtypharmacytimes.com/news/disease-modifying-multiple-sclerosis-drugs-may-increase-infection-risk
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
158 Views
Last post June 30, 2019, 03:37:42 pm
by agate
0 Replies
59 Views
Last post July 12, 2021, 02:30:05 pm
by agate
0 Replies
51 Views
Last post July 12, 2021, 02:33:26 pm
by agate
0 Replies
18 Views
Last post May 20, 2022, 09:18:34 pm
by agate
0 Replies
24 Views
Last post June 16, 2022, 09:20:56 pm
by agate